Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Sanara MedTech Inc. - SIC # 3850 -
Ticker
Exchange
SIC #
Website
Latest Ticker
SMTI
Nasdaq
3850
sanaramedtech.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Sanara MedTech Inc.
Sanara MedTech Inc (SMTI) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
- May 12th, 2026 1:02 pm
Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)
- May 11th, 2026 2:50 pm
ICU Medical (ICUI) Tops Q1 Earnings and Revenue Estimates
- May 7th, 2026 5:05 pm
Insulet (PODD) Q1 Earnings and Revenues Top Estimates
- May 6th, 2026 6:25 am
How Sanara MedTech (SMTI) Is Reframing Its Growth Story Around A Steady US$34 Target
- May 5th, 2026 7:17 am
Sanara MedTech (SMTI) Q4 2025 Earnings Transcript
- May 4th, 2026 10:53 am
What Makes Sanara Medtech (SMTI) A Compelling Risk-Reward Opportunity?
- Apr 23rd, 2026 7:20 am
How The Sanara MedTech (SMTI) Story Is Shifting With New Targets And Growth Assumptions
- Apr 20th, 2026 9:06 am
Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026
- Apr 14th, 2026 5:30 am
Sanara MedTech Inc. Q4 2025 Earnings Call Summary
- Mar 25th, 2026 6:30 am
Sanara MedTech Inc (SMTI) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...
- Mar 24th, 2026 1:01 pm
Sanara MedTech Q4 Earnings Call Highlights
- Mar 24th, 2026 7:10 am
Sanara MedTech Inc. (SMTI) Q4 Earnings Miss Estimates
- Mar 24th, 2026 6:25 am
Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance
- Mar 24th, 2026 5:00 am
Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds
- Mar 11th, 2026 5:30 am
Evolus, Inc. (EOLS) Matches Q4 Earnings Estimates
- Mar 3rd, 2026 4:05 pm
Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026
- Mar 3rd, 2026 5:30 am
Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rd
- Feb 17th, 2026 5:30 am
Shareholders in Sanara MedTech (NASDAQ:SMTI) are in the red if they invested three years ago
- Feb 13th, 2026 4:09 am
Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance
- Jan 23rd, 2026 5:30 am
Scroll